Last reviewed · How we verify

NCT06627829

Effect of Different Grafting Material Following Surgically Facilitated Orthodontics Therapy

Not yet recruiting NA Last updated 4 October 2024
What this trial tests

NA trial testing Surgically facilitated orthodontics therapy (SFOT) using allograft in Malocclusion, Angle Class I in 24 participants. Not yet recruiting.

Timeline
6 January 2025
Primary endpoint
6 January 2026
6 January 2027

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment24
Start date6 January 2025
Primary completion6 January 2026
Estimated completion6 January 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

18 and older, any sex, with Malocclusion, Angle Class I. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to quantitatively investigate the radiographic changes of alveolar bone, and gingival tissue changes of the mandibular anterior teeth in experimental group A receiving SFOT using freeze-dried allograft with a collagen membrane, experimental group B receiving SFOT using particulate xenograft covered by a collagen membrane and control group receiving only orthodontics therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Malocclusion, Angle Class I

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06627829.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing